AUTH/2824/2/16: Anonymous v Chiesi — Alleged customer visits by unvalidated field staff (No breach) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2824/2/16
Parties	Anonymous v Chiesi
Issue	Alleged customer visits/promotion by new field staff before completion of validation/training
Complaint received	24 February 2016
Case completed	18 April 2016
Applicable Code year	2016
Clauses considered	Clause 2; Clause 9.1; Clause 15.1
Decision	No breach of the Code
Appeal	No appeal
Notable observation	Panel concerned shadow-week “no promotion” instruction was verbal-only; Panel also noted two ITC slide sets had not been re-approved for the 2016 ITC and requested Chiesi be advised of concerns

Download the full case report (PDF)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

What happened

⌄

An anonymous complainant alleged a regional business manager (RBM) and a new account executive visited customers in a named location before they were fully trained/validated and compliant on Chiesi products.
The two employees had joined in January 2016 and were on a 5-week initial training course (ITC), with week 3 being a field-based “shadow week”.
Chiesi said both employees completed training and validations (via its LMS) on pharmacovigilance, the Code, relevant SPCs (including NextHaler COPD, high strength Fostair and NextHaler), SOPs, and a final respiratory knowledge validation.
Chiesi stated delegates were verbally briefed that they were not signed off to promote and must not engage in promotional/product discussions during the shadow week.
Chiesi’s internal investigation found no evidence the employees visited the named location during the shadow week.
On 5 February (orientation day), they visited surgeries to leave contact details; a nurse requested placebo devices and the RBM acknowledged the request but stated they could not engage in conversation until training was completed; another practice discussed the types of meetings pharma could potentially support (Chiesi said no product promotion occurred).
Separately, Chiesi identified an internal compliance error: two slide sets used in the ITC had not been re-certified for use for the January/February 2016 ITC (last certified/re-certified in 2012/2013). A medical signatory reviewed them and said they were suitable for re-certification.

⚖️

Outcome

⌄

No breach of the Code was ruled.
No breach of Clause 15.1 (training/knowledge of representatives).
No breach of Clause 9.1 (high standards).
No breach of Clause 2.
The Panel asked that Chiesi be advised of its concerns about the use of slide sets that had not been re-approved, given the importance of certification to self-regulation.

🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

AUTH/2824/2/16: Anonymous v Chiesi — Alleged customer visits by unvalidated field staff (No breach)

Key facts

What happened

Outcome

Clauses

Unlock the full case analysis

AQP Flagship Path — the complete UK ABPI signatory programme

📰 Weekly PMCPA Case Breakdown